Scope of IJBT

We welcome submissions that address the science and practice of safe blood transfusion. Priority topics include donor screening, component manufacturing, immunohematology, hemovigilance, and transfusion outcomes.

• Donor recruitment, eligibility, and infectious disease screening
• Blood component processing, storage, and pathogen reduction
• Immunohematology, blood group serology, and antibody identification
• Transfusion reactions, adverse events, and hemovigilance systems
• Patient blood management and clinical transfusion guidelines
• Apheresis, cellular therapy, and advanced transfusion technologies

Article Types

IJBT publishes original research, systematic reviews, meta analyses, brief reports, case studies, quality improvement studies, and clinical guidelines that strengthen transfusion practice.

• Original research and multicenter studies
• Clinical practice guidelines and consensus statements
• Quality improvement and operational studies
• Case reports and methodological innovations

Why Publish in IJBT

Your work is evaluated by specialists who understand transfusion medicine, regulatory requirements, and the clinical implications of blood safety findings. Open access ensures rapid global visibility and citation potential.

We emphasize clear reporting, ethical compliance, and practical relevance so published studies can be translated into safer transfusion protocols and improved patient outcomes.

Clinical Impact and Publishing Value

IJBT prioritizes blood safety, clinical relevance, and transparent reporting for transfusion medicine research.

Special Issue Priorities

We encourage submissions aligned with emerging transfusion priorities including pathogen surveillance, donor diversity, and patient blood management innovations.

Operational and Quality Studies

Operational research from blood centers and hospital transfusion services is welcome, especially studies on workflow efficiency, quality management, and compliance improvements.

Early Career Contributions

IJBT supports early career researchers and trainees with constructive peer review and editorial guidance to build strong transfusion medicine portfolios. Mentored submissions and collaborative studies are encouraged.

Emerging Pathogens and Safety Alerts

We invite rapid communications on emerging infectious risks, screening innovations, and hemovigilance findings that require timely dissemination to protect donors and recipients.

Technology and Innovation

Submissions on pathogen reduction, automated compatibility testing, data analytics, and decision support tools are encouraged. We welcome evidence that improves safety, efficiency, or clinical outcomes.

Pilot studies are welcome when they show measurable safety improvements or workflow gains with clear baseline comparisons.

Global Health Perspectives

Studies addressing transfusion challenges in resource limited settings, donor recruitment, and supply chain resilience are valuable to the global blood community.

Submission Readiness

Manuscripts should include clear methodology, ethical approvals, and data availability statements. Transparent reporting improves review quality and supports evidence based adoption.

Peer Review Focus

Reviewers assess clinical impact, statistical rigor, and operational relevance. We prioritize studies that can inform policy or practice across transfusion services.

Strong methodology and clear clinical implications are essential for publication for all submissions.

Transfusion Reactions and Hemovigilance

We welcome investigations into acute and delayed transfusion reactions, hemovigilance reporting systems, and strategies to reduce adverse events in clinical settings.

Component Therapy and Storage

Research on red cell, platelet, plasma, and cryoprecipitate processing, storage lesions, and component optimization is encouraged, especially when it improves outcomes or safety.

Cellular Therapy and Apheresis

Submissions on apheresis protocols, cellular therapy manufacturing, and monitoring of cellular therapy safety are aligned with IJBT scope and readership needs.

Donor Experience and Diversity

Studies that improve donor recruitment, retention, and inclusivity help build resilient blood supplies. We welcome evidence based strategies from regional and national programs.

Massive Transfusion and Critical Care

We encourage studies on massive transfusion protocols, trauma resuscitation, surgical transfusion pathways, and pediatric or neonatal transfusion strategies.

Quality Management and Regulation

Submissions that address regulatory compliance, accreditation readiness, and quality management systems help elevate transfusion practice across institutions.

Economic and Utilization Studies

Analyses of blood product utilization, inventory management, and cost effectiveness can inform hospital policy and strengthen patient blood management initiatives.

Rare Blood and Immunohematology

We encourage case series and methodological reports on rare blood groups, complex antibody identification, and transfusion support for alloimmunized patients.

Education and Training

Studies evaluating transfusion medicine education, competency programs, and laboratory training models are welcome when they demonstrate measurable improvements in practice.

Submission Checklist

Ensure manuscripts include clear objectives, detailed methods, ethical approvals, and data availability statements. Provide figures and tables that align with results and note any supplementary files or protocols.

Well prepared submissions move through peer review faster and improve the likelihood of timely publication.

If your study involves blood donors or recipients, include consent language and confirm adherence to local and international standards for transfusion research.